| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |